Advanced Medical Optics, Inc. (AMO) [NYSE:EYE],
a global leader in ophthalmic surgical devices and eye care products,
today announced the appointment of Richard J. DeRisio to vice president,
global regulatory affairs.
DeRisio will oversee development and execution of worldwide regulatory
strategies for AMO's new and existing
products, which are sold in more than 70 countries.
?We are pleased to welcome aboard Richard, as
he brings to AMO more than 25 years of regulatory and professional
management experience in the medical device industry,?
said AMO Executive Vice President, Research and Development Leonard
Borrmann. ?Richard's
knowledge and expertise will help us continue to strengthen our global
R&D leadership team and support AMO's
growth across its three businesses.?
Most recently, DeRisio served as vice president, global regulatory
affairs at Kinetic Concepts Incorporated, a high growth medical
technology company. He has held similar positions at cutting edge device
companies including STERIS Corporation, Computer Motion Incorporated,
Johnson & Johnson's Biosense Webster
Incorporated, Sorin Biomedical, and Ventritex Incorporated.
DeRisio received a bachelor's degree in
chemical engineering and a master's degree in
food science & technology from Cornell University.
About Advanced Medical Optics (AMO)
AMO develops advanced, life-improving vision technologies for people of
all ages. Products in the cataract/implant line include intraocular
lenses (IOLs), phacoemulsification systems, viscoelastics, and related
products used in ocular surgery. AMO owns or has the rights to such
product brands as ReZoom®,
Tecnis®, Clariflex®,
Sensar®, and Verisyse®
IOLs, Sovereign®,
Sovereign® Compact
and WhiteStar Signature?
phacoemulsification systems with WhiteStar®
technology, Healon®
viscoelastics, and the Baerveldt®
glaucoma shunt. Products in the laser vision correction line include
wavefront diagnostic devices, femtosecond lasers and associated patient
interface devices, and excimer laser vision correction systems and
treatment cards. AMO brands in the laser vision correction business
include Star S4 IR®,
WaveScan Wavefront®,
Advanced CustomVue?,
IntraLase®
FS, IntraLase Method?
and IntraLasik®.
Products in the contact lens care line include disinfecting solutions,
enzymatic cleaners and lens rewetting drops. Among the eye care product
brands the company possesses are COMPLETE®,
COMPLETE®
Blink-N-Clean®,
Consept®F, Consept®
1 Step, Oxysept® 1
Step, UltraCare®,
Ultrazyme®, Total
Care? and blink?
branded products. AMO is based in Santa Ana, California, and employs
approximately 4,200 worldwide. The company has operations in 24
countries and markets products in approximately 60 countries. For more
information, visit the company's Website at www.amo-inc.com.
Advanced Medical Optics, Inc.
Investors:
Sheree Aronson,
Corporate Vice President,
Investor Relations and Corporate
Communications
714-247-8290
sheree.aronson@amo-inc.com
or
Mark
Levin, Manager, Investor Relations, 714-247-8465
mark.levin@amo-inc.com
or
Media:
Steve
Chesterman, Manager, Corporate Communications
714-247-8711
steve.chesterman@amo-inc.com
bourse
